Xofigo – Radium Ra‑223‑dichloride uses, dose and side effects
Xofigo is used to treat adults with advanced, castration-resistant prostate cancer developing after at least two other cancer treatments except treatment to maintain reduced levels of male sex hormone (hormone therapy), or when other cancer treatment is not possible. Castration-resistant prostate cancer is a cancer that does not respond to treatment that reduces male sex hormones. Xofigo is only used when the disease has spread to the bones and is causing symptoms (eg pain), but without known spread to other internal organs.
Read More